Chronic morphine treatment decreases the Cav1.3 subunit of the L-type calcium channel

European Journal of Pharmacology

Volumn 578, Issue 2-3, 2008, Pages 101-107

  Haller, Victoria L ^a   Bernstein, Marissa A ^a   Welch, Sandra P ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Calcium channel; Dihydropyridin; Morphine; Opioid tolerance; Protein kinase A

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CALCIUM ION; CONOTOXIN; DIHYDROPYRIDINE; LIGAND; MORPHINE; OPIATE; PROTEIN SUBUNIT; RECEPTOR PROTEIN; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; IMMUNOASSAY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ANALGESICS, OPIOID; ANIMALS; BLOTTING, WESTERN; CALCIUM; CALCIUM CHANNELS, L-TYPE; CALCIUM CHANNELS, N-TYPE; DOWN-REGULATION; DRUG TOLERANCE; INJECTIONS, SUBCUTANEOUS; MALE; MESENCEPHALON; MICE; MICE, INBRED ICR; MOLECULAR WEIGHT; MORPHINE; PAIN MEASUREMENT; PAIN THRESHOLD; PHOSPHORYLATION; PROTEIN SUBUNITS; TIME FACTORS;

EID: 37349045964     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.09.003     Document Type: Article

References (68)

1. Antkieciwz-Michaluk L., Michaluk J., Romanska I., and Vetulani J. Cortical dihydropyridine binding sites and a behavioral syndrome in morphine-abstinent rats. Eur. J. Pharmacol. 180 (1990) 129-135
2. Antkiewicz-Michaluk L., Michaluk J., Romanska I., and Vetulani J. Reduction of morphine dependence and potentiation of analgesia by chronic co-administration of nifedipine. Psychopharmacology 111 (1993) 457-464
3. Armstrong D., and Eckert R. Voltage-activated calcium channels that must be phosphorylated to respond to membrane depolarization. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 2518-2522
4. Beitner D.B., Duman R.S., and Nestler E.J. A novel action of morphine in the rat Locus coeruleus: persistent decrease in adenylate cyclase. Mol. Pharmacol. 35 (1989) 559-564
5. Bernstein M.A., and Welch S.P. Alterations in L-type calcium channels in the brain and spinal cord of acutely treated and morphine-tolerant mice. Brain Res. 696 (1995) 83-88
6. Bernstein M.A., and Welch S.P. Effects of spinal versus supraspinal administration of cyclic nucleotide-dependent protein kinase inhibitors on morphine tolerance in mice. Drug Alcohol Depend. 44 (1997) 41-46
7. Bourinet E., Soong T.W., Stea A., and Snutch T.P. Determinants of the G protein-dependent opioid modulation of neuronal calcium channels. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 1486-1491
8. Cardenas H.L., and Ross D.H. Morphine-induced calcium depletion in discrete regions of rat brain. J. Neurochem. 24 (1975) 487-493
9. Cardenas H.L., and Ross D.H. Calcium depletions of synaptosomes after morphine treatment. Br. J. Pharmacol. 57 (1976) 521-526
10. Casey G., Nortcliffe S.A., Sharpe P., and Buggy D.J. Perioperative nimodipine and postoperative analgesia. Anest. Analg. 102 (2006) 504-508
11. 2+ channels. Annu. Rev. Cell Dev. Biol. 16 (2000) 521-555
12. Catterall W.A., Striessnig J., Snutch T.P., and Perez-Reyes E. International Union of Pharmacology.XL. Compendium of voltage-gated ion channels: calcium channels. Pharmacol. Rev. 55 (2003) 579-581
13. D'Amour F.E., and Smith D.L. A method of determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72 (1941) 74-79
14. Diaz A., Ruiz F., Florez J., Pazos A., and Hurle M.A. Regulation of dihydropyridine-sensitive Ca++ channels during opioid tolerance and supersensitivity in rats. J. Pharmacol. Exp. Ther. 274 (1995) 1538-1544
15. Eisfeld J., Mikala G., Schwartz A., Varadi G., and Klockner U. Lack of involvement of protein kinase A phosphorylation in voltage-dependent facilitation of the activity of human cardiac L-type calcium channels. Biochem. Biophys. Res. Commun. 221 (1996) 446-453
16. Fleming L.M., Ponjee G., and Childers S.R. Inhibition of protein phosphorylation by opioid-inhibited adenylyl cyclase in rat brain membranes. J. Pharmacol. Exp. Ther. 260 (1992) 1416-1424
17. 2+-channel blockers potentiate morphine analgesia in mice. Life Sci. 73 (2003) 2873-2881
18. 3H]nimodipine receptor binding in rat brain regions. Neurochem. Res. 13 (1988) 1175-1181
19. Guerrero-Munoz F., Cerreta K., Guerrero M.L., and Way E.L. Effects of morphine on synaptosomal calcium uptake. J. Pharmacol. Exp. Ther. 209 (1979) 132-136
20. Guerrero-Munoz F., and Fearon Z. Opioids/opiates and analgesic response modified by calcium. Life Sci. 31 (1982) 1237-1240
21. Guitart X., Hayward M.D., Nisenbaum L.K., Beitner D.B., Haycock J.W., and Nestler E.J. Indentification of MARPP-58, a morphine- and cyclic AMP-regulated phosphoprotein of 58 kDa, as tyrosine hydroxylase: evidence for regulation of its expression by chronic morphine in the rat Locus coeruleus. J. Neurosci. 10 (1990) 2649-2659
22. Guitart X., and Nestler E.J. Second messenger and protein phosphorylation mechanisms underlying opiate addiction: studies in the rat Locus coeruleus. Neurochem. Res. 18 (1993) 5-13
23. Hano K., Kaneto H., and Kakunaga T. Significance of calcium ion in the morphine analgesia. Jpn. J. Pharmacol. 14 (1964) 227-229
24. Harris L.S., and Pierson A.K. Some narcotic antagonists in the benzomorphan series. J. Pharmacol. Exp. Ther. 143 (1964) 141-148
25. Harris R.A., Yamamoto H., Loh H.H., and Way E.L. Alterations in brain calcium localization during the development of morphine tolerance and dependence. In: Kosterlitz H.W. (Ed). Opiates and Endogenous Opioid Peptides (1976), Elsevier Press, New York 361-368
26. Harris R.A., Yamamoto H., Loh H.H., and Way E.L. Discrete changes in brain calcium with morphine analgesia, tolerance-dependence, and abstinence. Life Sci. 20 (1977) 501-506
27. Hell J.W., Westenbroek R.E., Warner C., Ahlijanian M.K., Prystay W., Gilbert M.M., Snutch T.P., and Catterall W.A. Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha-1 subunits. J. Cell Biol. 123 (1993) 949-962
28. Hell J.W., Yokoyama C.T., Wong S.T., Warner C., Snutch T.P., and Catterall W.A. Differential phosphorylation of two size forms of the neuronal class C L-type calcium channel alpha-1 subunit. J. Biol. Chem. 268 (1993) 19451-19457
29. Hoffmeister F., and Tettenborn D. Calcium channel agonists and antagonists of the dihydropyridine type: antinociceptive effects, interference with opiate-mu-receptor agonists and neuropharmacological actions in rodents. Psychopharmacology 90 (1986) 299-307
30. Kakunaga T., Kaneto H., and Kotobuki H. Pharmacologic studies on analgesics, VII. Significance of the calcium ion in morphine analgesia. J. Pharmacol. Exp. Ther. 153 (1966) 134-141
31. 2+ channel through phosphorylation of its alpha-1 subunit. J. Biochem. 120 (1996) 170-176
32. Kavalali E.T., Hwang K.S., and Plummer M.R. cAMP-dependent enhancement of dihydropyridine-sensitive calcium channel availability in hippocampal neurons. J. Neurosci. 17 (1997) 5334-5348
33. Konno F., and Takayanagi I. Effects of morphine, codeine, and codeine-epoxide on calcium uptake into the synaptosomes isolated from naive and tolerant rats. Jpn. J. Pharmacol. 32 (1982) 1143-1150
34. Konno F., and Takayanagi I. Relationship between synaptosomal calcium uptake and antinociceptive action of morphine. Jpn. J. Pharmacol. 33 (1983) 619-626
35. Kuzmin A.V., Patkina N.A., and Zvartau E.E. Analgesic and reinforcing effects of morphine in mice. Influence of Bay K-8644 and nimodipine. Brain Res. 652 (1994) 1-8
36. Litchfield S.T., and Wilcoxon F. A simplified method of evaluating dose effect experiments. J. Pharmacol. Exp. Ther. 96 (1949) 99-113
37. Lux F., Welch S.P., Brase D.A., and Dewey W.L. Interaction of morphine with intrathecally administered calcium and calcium antagonists: evidence for supraspinal endogenous opioid mediation of intrathecal calcium-induced antinociception in mice. J. Pharmacol. Exp. Ther. 246 (1988) 500-507
38. Mackler S.A., and Eberwine J.H. Cellular adaptation to opiates alters ion-channel mRNA levels. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 385-389
39. Michaluk J., Karolewicz B., Antkiewicz-Michaluk L., and Vetulani J. Effects of various Ca2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat. Eur. J. Pharmacol. 352 (1998) 189-197
40. Moises H.C., Rusin K.I., and Macdonald R.L. Mu-opioid receptor-mediated reduction of neuronal calcium current occurs via a Go-type GTP-binding protein. J. Neurosci. 14 (1994) 3842-3851
41. Nah S.Y., Saya D., Barg J., and Vogel Z. Opiate receptor agonists regulate phosphorylation of synapsin I in cocultures of rat spinal cord and dorsal root ganglion. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 4052-4056
42. Nestler E.J., and Tallman J.F. Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat Locus coeruleus. Mol. Pharmacol. 33 (1988) 127-132
43. Ohnishi T., Saito K., Matsumoto K., Sakuda M., and Inoki R. Decrease in analgesic effect of nifedipine following chronic morphine administration. Eur. J. Pharmacol. 158 (1988) 173-175
44. Pereira I.T., Prado W.A., and Dos Reis M.P. Enhancement of epidural morphine-induced analgesia by systemic nifedipine. Pain 53 (1993) 341-355
45. Perez-Reyes E., Yuan W., Wei X., and Bers D.M. Regulation of the cloned L-type cardiac calcium channel by cyclic-AMP-dependent protein kinase. FEBS Lett. 342 (1994) 119-123
46. 2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells. Mol. Pharmacol. 47 (1995) 1041-1049
47. Ramkumar V., and El-Fakahany E.E. Prolonged morphine treatment increases rat brain dihydropyridine binding sites: possible involvement in development of morphine dependence. Eur. J. Pharmacol. 146 (1988) 73-83
48. Roca G., Aguilar J.L., Gomar C., Mazo V., Costa J., and Vidal F. Nimodipine fails to enhance the analgesic effect of slow release morphine in the early phases of cancer pain treatment. Pain 68 (1996) 239-243
49. Ross D.H., Medina M.A., and Cardenas H.L. Morphine and ethanol: selective depletion of regional brain calcium. Science 186 (1974) 63-64
50. Ruiz F., Dierssen M., Florez J., and Hurle M.A. Potentiation of acute opioid-induced respiratory depression and reversal of tolerance by the calcium antagonist nimodipine in awake rats. Arch. Pharmacol. 348 (1993) 633-637
51. 3H]nitrendipine binding following chronic treatment with morphine. Neurochem. Int. 7 (1985) 1033-1036
52. Santillan R., Maestre J.M., Hurle M.A., and Florez J. Enhancement of opiate analgesia by nimodipine in cancer patients chronically treated with morphine: a preliminary report. Pain 58 (1994) 129-132
53. 2+ channels due to phosphorylation by cAMP-dependent protein kinase. Nature 364 (1993) 240-243
54. Sculptoreanu A., Rotman E., Takahashi M., Scheuer T., and Catterall W.A. Voltage-dependent potentiation of the activity of cardiac L-type calcium channel α1 subunits due to phosphorylation by cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 10135-10139
55. Smith F.L., Dombrowski D.S., and Dewey W.L. Involvement of intracellular calcium in morphine tolerance in mice. Pharmacol. Biochem. Behav. 62 (1999) 381-388
56. Snutch T.P., Tomlinson W.J., Leonard J.P., and Gilbert M.M. Distinct calcium channels are generated by alternative splicing and are differentially expressed in the mammalian CNS. Neuron 7 (1991) 45-57
57. Tiaho F., Richard S., Lory P., Nerbonne J.M., and Nargeot J. Cyclic-AMP-dependent phosphorylation modulates the stereospecific activation of cardiac Ca channels by Bay K 8644. Pflugers Arch. 417 (1990) 58-66
58. Varadi G., Mori Y., Mikala G., and Schwartz A. Molecular determinants of Ca2+ channel function and drug action. Trends Pharmacol. 16 (1995) 43-49
59. Welch S.P., and Bass P.P. Modulation of free intracellular calcium levels ([Ca2+]i) in brain and spinal cord of morphine-tolerant rats and mice. Pharmacol. Biochem. Behav. 51 (1995) 57-63
60. Welch S.P., and Olson K.G. Opiate tolerance-induced modulation of free intracellular calcium in synaptosomes. Life Sci. 48 (1991) 1853-1861
61. Wilding T.J., Womack M.D., and McCleskey E.W. Fast, local signal transduction between the mu opioid receptor and Ca2+ channels. J. Neurosci. 15 (1995) 4121-4132
62. Yamamoto H., Harris R.A., Loh H.H., and Way E.L. Effects of acute and chronic morphine treatments on calcium localization and binding in brain. J. Pharmacol. Exp. Ther. 205 (1978) 255-264
63. Yang J.C., Shan J., Ng K.F., and Pang P. Morphine and methadone have different effects on calcium channel currents in neuroblastoma cells. Brain Res. 870 (2000) 199-203
64. Zarauza R., Saez-Fernandez A.N., Iribarren M.J., Carrascosa F., Adame M., Fidalgo L., and Monedero P. A comparative study with oral nifedipine, intravenous nimodipine, and magnesium sulfate in postoperative analgesia. Anest. Analg. 91 (2000) 938-943
65. 2+ channels and their possible counterparts in mammalian CNS neurons. Neuropharmacology 32 (1993) 1075-1088
66. Zhang L., Yu Y., Mackin S., Weight F.F., Uhl G.R., and Wang J.B. Differential mu opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J. Biol. Chem. 271 (1996) 11449-11454
67. Zharkovsky A., Totterman A.M., Moisio J., and Ahtee L. Concurrent nimodipine attenuates the withdrawal signs and the increase of cerebral dihydropyridine binding after chronic morphine treatment in rats. Arch. Pharmacol. 347 (1993) 483-486
68. Zong X., Schreieck J., Mehrke G., Welling A., Schuster A., Bosse E., Flockerzi V., and Hofmann F. On the regulation of the expressed L-type calcium channel by cAMP-dependent phosphorylation. Pflugers Arch. 430 (1995) 340-347